Applied Therapeutics (APLT) Faces Acquisition Bid from Cycle Group Holdings

Applied Therapeutics (APLT) is involved in a tender offer by Cycle Group Holdings, with significant impacts on shareholders. The company is focused on rare metabolic diseases, but financial metrics indicate distress, with negative margins and a low Altman Z-Score, suggesting potential bankruptcy risk. The board remains dedicated to advancing govorestat, but failure of the offer could lead to liquidation, accelerated obligations, and a decline in stock price.